Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NVAX |
---|---|---|
09:32 ET | 50747 | 12.8796 |
09:34 ET | 26071 | 12.81 |
09:36 ET | 22502 | 12.87 |
09:38 ET | 10735 | 12.9024 |
09:39 ET | 34419 | 12.97 |
09:41 ET | 30430 | 13.04 |
09:43 ET | 41387 | 13.08 |
09:45 ET | 61037 | 13.12 |
09:48 ET | 43216 | 13.07 |
09:50 ET | 20777 | 13.1 |
09:52 ET | 16353 | 13.0194 |
09:54 ET | 48459 | 12.9 |
09:56 ET | 42700 | 13.05 |
09:57 ET | 35102 | 13.04 |
09:59 ET | 20553 | 13.02 |
10:01 ET | 20251 | 13.06 |
10:03 ET | 9907 | 13.01 |
10:06 ET | 13830 | 12.91 |
10:08 ET | 17388 | 13.0199 |
10:10 ET | 19059 | 13.01 |
10:12 ET | 20616 | 13.0501 |
10:14 ET | 8423 | 13.05 |
10:15 ET | 46370 | 13.14 |
10:17 ET | 96947 | 13.16 |
10:19 ET | 24778 | 13.19 |
10:21 ET | 22645 | 13.14 |
10:24 ET | 25791 | 13.1 |
10:26 ET | 20604 | 13.09 |
10:28 ET | 15466 | 13.04 |
10:30 ET | 40706 | 13.03 |
10:32 ET | 53698 | 12.98 |
10:33 ET | 20980 | 12.96 |
10:35 ET | 26582 | 12.96 |
10:37 ET | 29491 | 12.9498 |
10:39 ET | 9431 | 12.93 |
10:42 ET | 26851 | 12.89 |
10:44 ET | 12358 | 12.87 |
10:46 ET | 29728 | 12.83 |
10:48 ET | 39912 | 12.82 |
10:50 ET | 82046 | 12.77 |
10:51 ET | 40788 | 12.73 |
10:53 ET | 27513 | 12.7591 |
10:55 ET | 30681 | 12.755 |
10:57 ET | 20351 | 12.7563 |
11:00 ET | 59098 | 12.67 |
11:02 ET | 26778 | 12.7042 |
11:04 ET | 18401 | 12.655 |
11:06 ET | 16059 | 12.68 |
11:08 ET | 8465 | 12.67 |
11:09 ET | 14490 | 12.67 |
11:11 ET | 17735 | 12.66 |
11:13 ET | 27027 | 12.72 |
11:15 ET | 17912 | 12.71 |
11:18 ET | 4366 | 12.7101 |
11:20 ET | 13204 | 12.66 |
11:22 ET | 9172 | 12.705 |
11:24 ET | 19335 | 12.6899 |
11:26 ET | 18153 | 12.7 |
11:27 ET | 11878 | 12.67 |
11:29 ET | 13218 | 12.6797 |
11:31 ET | 16789 | 12.64 |
11:33 ET | 53552 | 12.595 |
11:36 ET | 29422 | 12.64 |
11:38 ET | 10508 | 12.63 |
11:40 ET | 6175 | 12.6 |
11:42 ET | 2859 | 12.62 |
11:44 ET | 14362 | 12.61 |
11:45 ET | 61054 | 12.56 |
11:47 ET | 17080 | 12.61 |
11:49 ET | 25233 | 12.59 |
11:51 ET | 67197 | 12.64 |
11:54 ET | 7487 | 12.62 |
11:56 ET | 54814 | 12.65 |
11:58 ET | 25292 | 12.57 |
12:00 ET | 128824 | 12.47 |
12:02 ET | 103454 | 12.61 |
12:03 ET | 20079 | 12.63 |
12:05 ET | 34933 | 12.605 |
12:07 ET | 19930 | 12.6005 |
12:09 ET | 3899 | 12.61 |
12:12 ET | 23943 | 12.545 |
12:14 ET | 18277 | 12.58 |
12:16 ET | 21174 | 12.575 |
12:18 ET | 11793 | 12.54 |
12:20 ET | 6032 | 12.52 |
12:21 ET | 11928 | 12.54 |
12:23 ET | 10579 | 12.54 |
12:25 ET | 5535 | 12.5523 |
12:27 ET | 14168 | 12.5601 |
12:30 ET | 19204 | 12.56 |
12:32 ET | 8245 | 12.545 |
12:34 ET | 31577 | 12.545 |
12:36 ET | 16586 | 12.545 |
12:38 ET | 21211 | 12.555 |
12:39 ET | 16922 | 12.524 |
12:41 ET | 43474 | 12.5099 |
12:43 ET | 51411 | 12.48 |
12:45 ET | 17479 | 12.485 |
12:48 ET | 31064 | 12.495 |
12:50 ET | 36242 | 12.52 |
12:52 ET | 44102 | 12.5198 |
12:54 ET | 18850 | 12.57 |
12:56 ET | 40188 | 12.56 |
12:57 ET | 46224 | 12.555 |
12:59 ET | 226500 | 12.55 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Novavax Inc | 1.8B | -4.0x | --- |
PTC Therapeutics Inc | 2.3B | -4.0x | --- |
ACADIA Pharmaceuticals Inc | 2.6B | -1,211.3x | --- |
Azenta Inc | 2.8B | -19.0x | --- |
P3 Health Partners Inc | 173.6M | -0.8x | --- |
Catalyst Pharmaceuticals Inc | 1.9B | 28.4x | --- |
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.8B |
---|---|
Revenue (TTM) | $996.6M |
Shares Outstanding | 140.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.98 |
EPS | $-3.18 |
Book Value | $-5.14 |
P/E Ratio | -4.0x |
Price/Sales (TTM) | 1.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -39.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.